New IBD therapies take the ‘if factor’ out of Crohn’s, ulcerative colitis
August 19, 2025
-
Books
-
Anti-TNF Therapy for Treatment of Extraintestinal Manifestations of Inflammatory Bowel Disease in Treatment of Inflammatory Bowel Disease with Biologics
Fudman DI, Flier SN (2017), Springer
-
Anti-TNF Therapy for Treatment of Extraintestinal Manifestations of Inflammatory Bowel Disease in Treatment of Inflammatory Bowel Disease with Biologics
-
Publications
-
Short-Term Use of Upadacitinib in Combination With Biologic Therapy for Inducing Clinical Remission in Patients With Active Inflammatory Bowel Disease.
Yin J, El-Najjar Y, Cordova N, Touma MJ, Nguyen N, Boktor M, Burstein E, Fudman DI, Inflammatory bowel diseases 2024 May -
Isolated gastrointestinal histoplasmosis with a negative urine antigen test mimicking ulcerative colitis flare: a case report.
Yin J, Balachandar N, Karamchandani D, Vemulapalli R, Fudman DI, Gastroenterology report 2024 12 goae013 -
Monitoring Postoperative Crohn's Disease-Closing the Gap.
Fudman DI, Digestive diseases and sciences 2023 Sep 68 9 3485-3487 -
Comparative Safety of Biologic Agents in Patients With Inflammatory Bowel Disease With Active or Recent Malignancy: A Multi-Center Cohort Study.
Holmer AK, Luo J, Russ KB, Park S, Yang JY, Ertem F, Dueker J, Nguyen V, Hong S, Zenger C, Axelrad JE, Sofia A, Petrov JC, Al-Bawardy B, Fudman DI, Llano E, Dailey J, Jangi S, Khakoo N, Damas OM, Barnes EL, Scott FI, Ungaro RC, Singh S, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2023 Jun 21 6 1598-1606.e5 -
Automated Clinical Pathway Utilizing Custom Risk Stratification Identifies Substantial Rates of Overdue Follow-up Among Patients With Inflammatory Bowel Disease and Facilitates Population Health Interventions.
Schroeder MK, Tan SA, Touma MJ, Basit M, Fudman DI, Inflammatory bowel diseases 2023 Mar -
Improved Healthcare Access Reduces Requirements for Surgery in Indigent IBD Patients Using Biologic Therapy: A 'Safety-Net' Hospital Experience.
Gu P, Clifford E, Gilman A, Chang C, Moss E, Fudman DI, Kilgore P, Cvek U, Trutschl M, Alexander JS, Burstein E, Boktor M, Pathophysiology : the official journal of the International Society for Pathophysiology 2022 Jul 29 3 383-393 -
Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease.
Alayo QA, Fenster M, Altayar O, Glassner KL, Llano E, Clark-Snustad K, Patel A, Kwapisz L, Yarur AJ, Cohen BL, Ciorba MA, Thomas D, Lee SD, Loftus EV, Fudman DI, Abraham BP, Colombel JF, Deepak P, Crohn's & colitis 360 2022 Jan 4 1 otac002 -
Decreased Antibody Responses to Ad26.COV2.S Relative to SARS-CoV-2 mRNA Vaccines in Patients With Inflammatory Bowel Disease.
Pozdnyakova V, Botwin GJ, Sobhani K, Prostko J, Braun J, Mcgovern DPB, Melmed GY, Appel K, Banty A, Feldman E, Ha C, Kumar R, Lee S, Rabizadeh S, Stein T, Syal G, Targan S, Vasiliauskas E, Ziring D, Debbas P, Hampton M, Mengesha E, Stewart JL, Frias EC, Cheng S, Ebinger J, Figueiredo JC, Boland B, Charabaty A, Chiorean M, Cohen E, Flynn A, Valentine J, Fudman D, Horizon A, Hou J, Hwang C, Lazarev M, Lum D, Fausel R, Reddy S, Mattar M, Metwally M, Ostrov A, Parekh N, Raffals L, Sheibani S, Siegel C, Wolf D, Younes Z, Gastroenterology 2021 12 161 6 2041-2043.e1 -
Prevalence of Forceps Polypectomy of Non-Diminutive Polyps is Substantial but Modifiable.
Fudman DI, Singal AG, Cooper MG, Lee M, Murphy CC, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2021 Nov -
Interventions to Decrease Unplanned Healthcare Utilization and Improve Quality of Care in Adults With Inflammatory Bowel Disease: A Systematic Review.
Fudman DI, Perez-Reyes AE, Niccum BA, Melmed GY, Khalili H, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2021 Sep -
Visceral Adipose Tissue Volumetrics Inform Odds of Treatment Response and Risk of Subsequent Surgery in IBD Patients Starting Antitumor Necrosis Factor Therapy.
Gu P, Chhabra A, Chittajallu P, Chang C, Mendez D, Gilman A, Fudman DI, Xi Y, Feagins LA, Inflammatory bowel diseases 2021 Jul -
Favorable Outcomes Combining Vedolizumab With Other Biologics or Tofacitinib for Treatment of Inflammatory Bowel Disease.
Llano EM, Shrestha S, Burstein E, Boktor M, Fudman DI, Crohn's & colitis 360 2021 Jul 3 3 otab030 -
Antibiotic prophylaxis and infectious complications in patients on peritoneal dialysis undergoing lower gastrointestinal endoscopy.
Clarke WT, Satyam VR, Fudman DI, Zullow S, Goyal KG, Byanova KL, Huang C, Feuerstein JD, Gastroenterology report 2020 Oct 8 5 407-409 -
Fragmentation, Care Models, and Improving Outcomes in Inflammatory Bowel Disease.
Fudman DI, Hou JK, JAMA network open 2020 09 3 9 e2016122 -
A phase 2B randomised trial of hyperbaric oxygen therapy for ulcerative colitis patients hospitalised for moderate to severe flares.
Dulai PS, Raffals LE, Hudesman D, Chiorean M, Cross R, Ahmed T, Winter M, Chang S, Fudman D, Sadler C, Chiu EL, Ross FL, Toups G, Murad MH, Sethuraman K, Holm JR, Guilliod R, Levine B, Buckey JC, Siegel CA, Alimentary pharmacology & therapeutics 2020 09 52 6 955-963 -
High Rate of Incomplete Consent for Colonoscopy: Identifying an Area for Improvement in Gastrointestinal Endoscopy.
Fudman DI, Roemi L, Leffler DA, Feuerstein JD, American journal of medical quality : the official journal of the American College of Medical Quality 2019 Aug 1062860619868296 -
Inpatient Management of Acute Severe Ulcerative Colitis.
Fudman DI, Sattler L, Feuerstein JD, Journal of hospital medicine 2019 May 14 E1-E8 -
Complication rates of trainee- versus attending-performed upper gastrointestinal endoscopy.
Fudman DI, Falchuk KR, Feuerstein JD, Annals of gastroenterology 2019 May-Jun 32 3 273-277 -
Effect of Consent and Educational Adjuncts to Consent on Patient Perceptions About Colonoscopy.
Fudman DI, Papamichael K, Roemi L, Rao V, Falchuk KR, Leffler DA, Feuerstein JD Journal of clinical gastroenterology 2018 Jul -
Predictors Of Treatment Failure After Radiofrequency Ablation For Intramucosal Adenocarcinoma in Barrett Esophagus: A Multi-institutional Retrospective Cohort Study.
Agoston AT, Strauss AC, Dulai PS, Hagen CE, Muzikansky A, Fudman DI, Abrams JA, Forcione DG, Jajoo K, Saltzman JR, Odze RD, Lauwers GY, Gordon SR, Lightdale CJ, Rothstein RI, Srivastava A The American journal of surgical pathology 2016 Apr 40 4 554-62 -
Positive correlation between endoscopist radiofrequency ablation volume and response rates in Barrett's esophagus.
Fudman DI, Lightdale CJ, Poneros JM, Ginsberg GG, Falk GW, Demarshall M, Gupta M, Iyer PG, Lutzke L, Wang KK, Abrams JA Gastrointestinal endoscopy 2014 Jul 80 1 71-7 -
Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a US Multicenter Consortium.
Gupta M, Iyer PG, Lutzke L, Gorospe EC, Abrams JA, Falk GW, Ginsberg GG, Rustgi AK, Lightdale CJ, Wang TC, Fudman DI, Poneros JM, Wang KK Gastroenterology 2013 Jul 145 1 79-86.e1
-
Short-Term Use of Upadacitinib in Combination With Biologic Therapy for Inducing Clinical Remission in Patients With Active Inflammatory Bowel Disease.